22 July 2019
Judges Scientific plc
("Judges Scientific", "Judges", the "Company" or the "Group")
Appointment of Liberum as Joint Broker
Judges Scientific, a group engaged in the buy and build of scientific instrument businesses, is pleased to announce the appointment of Liberum Capital Limited ("Liberum") as its Joint Broker with immediate effect. Shore Capital will continue to act as the Company's Nominated Adviser & Joint Broker.
- Ends -
Judges Scientific | ||
David Cicurel, CEO Brad Ormsby, Group FD | Tel: +44 (0) 203 829 6970 | |
Shore Capital (Nominated Adviser & Joint Broker) | ||
Stephane Auton Edward Mansfield | Tel: +44 (0) 20 7408 4090 | |
Liberum (Joint Broker) | ||
Bidhi Bhoma Euan Brown | Tel: +44 (0) 20 3100 2222 | |
Media enquiries: Alma PR (Financial Public Relations) | ||
Rebecca Sanders-Hewett Sam Modlin | Tel: +44 (0) 20 3405 0205 | |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group engaged in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export.
Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, payment of increasing dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
For further information, please visit www.judges.uk.com